Cipher Pharmaceuticals, Inc.

Cipher Pharmaceuticals, Inc. has recently experienced a change in its evaluation, reflecting a shift in valuation metrics and technical indicators. The company showcases strong management efficiency and competitive positioning within the Pharmaceuticals & Biotechnology sector, supported by notable financial ratios and a positive trend in market sentiment.

Cipher Pharmaceuticals, Inc. has recently experienced a change in its evaluation, reflecting adjustments in its financial metrics and market position. The company showcases strong management efficiency and notable growth in net profit, alongside solid operating cash flow and sales figures, indicating a balanced valuation relative to industry standards.

Cipher Pharmaceuticals, Inc. has recently experienced a change in its evaluation, reflecting a more balanced assessment. Key financial metrics include a P/E ratio of 19 and a Price-to-Book Value of 2.07. The company has shown strong management efficiency with a 10.73% ROE and significant net profit growth of 116.61% in June 2025.